中医临床研究2026，Vol.18Issue(9)：51-54,4.DOI:10.3969/j.issn.1674-7860.2026.09.009
呼和浩特市2型糖尿病患者微血管病变相关因素分析
An analysis of the related factors of microvascular lesions in patients with type 2 diabetes in Hohhot city
摘要
Abstract
Objective:To explore the relationship among microvascular lesions in patients with type 2 diabetes mellitus(T2DM)in Hohhot city and the disease duration,BMI,smoking,alcohol consumption,and traditional Chinese medicine(TCM)syndrome patterns.Methods:A retrospective case study was used.The data on TCM syndrome type,age,gender,microvascular lesions,smoking history,and drinking history of 1 657 T2DM patients who met the enrollment standards were collected from January 1,2022 to December 31,2023.The data on TCM syndrome type,age,gender,microvascular lesions,smoking history,and alcohol consumption history were collected from 1 657 T2DM patients who met the enrollment standards.Statistical analyses were performed by using SPSS 22.0 and EXCEL software.Results:Qi(气)and Yin(阴)deficiency syndrome was the most common pathological basis in the middle and late stages of type 2 diabetes,and was an important pathogenic basis for the occurrence of microvascular complications.There was no statistical difference among microvascular lesions smoking and drinking(P>0.05).The disease duration was identified the strongest risk factor for microvascular lesions.As the disease duration was prolonged,the incidence of diabetic nephropathy and diabetic retinopathy was significantly and continuously increasing.Weight control was particularly significance to prevent diabetic nephropathy.Conclusion:Type 2 diabetes microvascular lesions in Hohhot are associated with TCM syndrome type,BMI,and disease duration,and it has little correlation with alcohol consumption and smoking.关键词
内分泌/2型糖尿病/微血管病变Key words
Endocrine/Type 2 diabetes mellitus/Microvascular lesion分类
医药卫生引用本文复制引用
李广称,邢丽娜,骆仲凯,党林林,刁雪茹,安慕洁,王权..呼和浩特市2型糖尿病患者微血管病变相关因素分析[J].中医临床研究,2026,18(9):51-54,4.基金项目
省部共建中医湿证国家重点实验室工作站开放课题(SZGZZ20240044):2型糖尿病湿证病机演变规律及其物质基础的队列研究. （SZGZZ20240044）
